Navigation Links
Jesper Bramming, former A.P. Moller Executive, Joins the CMC Biologics Executive Management Team as Chief Financial Officer
Date:1/7/2014

COPENHAGEN, Denmark and SEATTLE, Jan. 7, 2014 /PRNewswire/ -- CMC Biologics, a leading biopharmaceutical process development and biopharmaceutical manufacturing organization, announced today that it has appointed Jesper Bramming as Chief Financial Officer (CFO) of its global operations.

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

Jesper Bramming brings more than 25 years of financial and management experience to CMC Biologics' Executive Management Team, including 9 years as CFO at financial service provider Nets Holding and in two subsidiaries in A. P. Moller – Maersk Group: Maersk Oil & Gas and Svitzer.

Mr. Bramming has previously held international management positions as an equity portfolio manager and financial analyst at A. P. Moller Maersk and within the banking industry. He holds a Master of Economics from the University of Copenhagen and has completed executive education programs at Columbia University, including the Columbia Senior Executive Program.

"We're very pleased to welcome Jesper to our global executive team managing financial operations in both Copenhagen and North American. The breadth of his international finance and financial services expertise is impressive, and we expect him to play a key role in preparing CMC Biologics for its next phase of success," said Claes Glassell, Chief Executive Officer of CMC Biologics.

"CMC Biologics has outstanding process development and manufacturing expertise to serve sophisticated clinical and commercial biopharmaceutical markets," said Jesper Bramming. "I am excited to join the company as it embarks on a new level of growth and I look forward to contributing to the team's execution of its development plan."

About CMC Biologics
CMC Biologics is committed to delivering world class biopharmaceutical process development and manufacturing services, specializing in custom services for scale up and cGMP manufacture of protein-based therapeutics for preclinical, clinical trials, and commercial production. The Company's fully integrated services includes cell line development using its proprietary CHEF1® system, process and formulation development, and comprehensive analytical testing. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers stirred tank and perfusion production processes. To learn more, visit www.cmcbiologics.com.

Media Contacts:
Stacie D. Byars
CMC Biologics Global Marketing
sbyars@cmcbio.com
+1 (206) 660-2588


'/>"/>
SOURCE CMC Biologics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cargill’s Dielectric Transformer Oil Made from Natural Esters Wins Presidential Green Chemistry Award
2. Everest Group Recognizes TCS as a Global Leader and Star Performer in Life Sciences IT Outsourcing
3. Regado Biosciences, Inc. Appoints World-Renowned Leader in Cardiovascular Research and Former Global Head of Cardiovascular Diseases for Merck & Co., to Board of Directors
4. McCord Research Hires Former University of Iowa Researcher
5. Former Life Technologies and BD Biosciences Executive John L. "Kip" Miller Joins Solulinks Board of Directors
6. Former Head of UK Medicines & Healthcare Products Regulatory Agency (MHRA) Sir Alasdair Breckenridge Joins NDA Partners
7. Former COO and CSO of IDEXX Laboratories, Inc. Joins Board of Directors for Vet-Stem, Inc.
8. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
9. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
10. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
11. Utah, There is No Better Place U.S. Chamber of Commerce Ranks Utah as the Top Performer in the Nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 2017 , ... Litmus Health , a clinical data ... board. The board comprises leaders spanning business, technology, academia, and pharmaceutical research. The ... Engineering, to Chief Technology Officer. Crooks will lead strategy and development of the ...
(Date:7/20/2017)... July 20, 2017   KCNQ2 Cure Alliance ... evaluations company, today announced that they have completed ... genetic mutation implicated in KCNQ2 epileptic encephalopathy. They ... a second case involving an additional KCNQ2 genetic ... Alliance and Pairnomix entered into a collaboration to ...
(Date:7/18/2017)... Diego, CA (PRWEB) , ... July 18, 2017 ... ... graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of a ... The new biosensor chip enables researchers to study the kinetics of polyhistidine-tagged (His-tagged) ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... ... from the United States Patent and Trademark Office for its Patent Applications 14/858,857 ... Trademark Office’s allowances of these patent applications further expand the protection of G-CON’s ...
Breaking Biology Technology:
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/19/2017)... , April 19, 2017 The ... vendor landscape is marked by the presence of several ... however held by five major players - 3M Cogent, ... companies accounted for nearly 61% of the global military ... companies in the global military biometrics market boast global ...
Breaking Biology News(10 mins):